Access Biotechnology Archives - FinSMEs

Home ยป Access Biotechnology

Skip to content

FinSMEs

FinSMEs FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

  • Facebook
  • Twitter
  • Linkedin
Navigation

Site navigation

  • USA
  • UK
  • Germany
  • Canada
  • China
  • Russia
  • India
  • France
  • Italy
  • NFT
  • Home
  • Access Biotechnology

Access Biotechnology

Hemab Therapeutics
DenmarkUSA

Hemab Therapeutics Raises $135M in Series B Financing

Published on February 21, 2023February 21, 2023By FinSMEs
Matchpoint
USA

Matchpoint Therapeutics Raises $100M in Series A and Seed Funding

Published on October 17, 2022October 17, 2022By FinSMEs
acelyrin Logo
USA

Acelyrin Raises $300M Series C Financing

Published on September 13, 2022September 13, 2022By FinSMEs
Upstream_logo
USA

Upstream Bio Raises $200M in Series A Financing

Published on June 2, 2022June 2, 2022By FinSMEs
Disc Medicine
USA

Disc Medicine Raises $90M in Series B Funding

Published on September 2, 2021September 2, 2021By FinSMEs
Eliem Therapeutics
UKUSA

Eliem Therapeutics Launches with $80M in Financing

Published on April 2, 2021April 2, 2021By FinSMEs
dtx
USA

DTx Pharma Closes $100M Series B Financing

Published on March 5, 2021By FinSMEs
cancer
USA

Day One Biopharma Raises $60M in Series A Funding

Published on May 22, 2020May 22, 2020By FinSMEs
healthcare
USA

Pandion Therapeutics Closes $80M Series B Financing

Published on April 1, 2020April 1, 2020By FinSMEs
healthcare
USA

Disc Medicine Raises $50M in Series A Financing

Published on October 30, 2019By FinSMEs
trefoil
USA

Trefoil Therapeutics Raises $28M in Series A Funding

Published on July 16, 2019By FinSMEs

The Daily Deal Newsletter – Sign Up

About | Advertise | Contact | Terms & Conditions | Disclaimer | News | The Daily Deal Newsletter

Privacy Policy
FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: [email protected]

Follow FinSMEs on: